These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3363660)

  • 1. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solutions of cyclosporine.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):640. PubMed ID: 3363660
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Clin Transpl; 1989; ():324. PubMed ID: 2487599
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Transplantation; 1990 Apr; 49(4):823-4. PubMed ID: 2326881
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of allergic reaction to cyclosporin capsules in patient allergic to standard oral and intravenous solution of cyclosporin.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Lancet; 1987 Dec; 2(8573):1456. PubMed ID: 2892007
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome.
    Vernillet L; Moulin B; Dadoun C; Le Bigot JF; Fillastre JP
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):529-35. PubMed ID: 3363653
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.
    Nashan B; Bleck J; Wonigeit K; Vogt P; Christians U; Sewing KF; Beveridge T; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):637-9. PubMed ID: 3284113
    [No Abstract]   [Full Text] [Related]  

  • 7. Low predictive value of cyclosporine level for efficacy or renal dysfunction in psoriasis and idiopathic nephrotic syndrome.
    Feutren G; Miller C
    Transplant Proc; 1990 Jun; 22(3):1299-302. PubMed ID: 2349691
    [No Abstract]   [Full Text] [Related]  

  • 8. Dosage forms of cyclosporine.
    Yee GC
    Pharmacotherapy; 1991; 11(6):149S-152S. PubMed ID: 1771140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient.
    Takamatsu Y; Ishizu M; Ichinose I; Ogata K; Onoue M; Kumagawa M; Suzumiya J; Tamura K
    Bone Marrow Transplant; 2001 Aug; 28(4):421-3. PubMed ID: 11571519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous cyclosporine A for patients with nephrotic syndrome.
    Proesmans W; De Rooster A; Van Dyck M
    Pediatr Nephrol; 2001 Feb; 16(2):196-7. PubMed ID: 11261692
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of cyclosporine with low-dose prednisone compared with high-dose prednisone in nephrotic syndrome.
    Tejani A; Gonzalez R; Rajpoot D; Sharma R; Pomrantz A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):262-4. PubMed ID: 3381280
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine and other therapy-resistant nephrotic syndrome.
    van Hooff JP; Leunissen KM; Havenith MG; Bosman FT
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):293-6. PubMed ID: 3381286
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
    Bruelisauer A; Kawai R; Misslin P; Lemaire M
    Drug Metab Dispos; 1994; 22(2):194-9. PubMed ID: 8013274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A capsules: bioavailability and clinical acceptance study in renal transplant patients.
    Zehnder C; Beveridge T; Nüesch E; Abisch A; Thiel G
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):641-3. PubMed ID: 3284114
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of obesity on cyclosporine pharmacokinetics in uremic patients.
    Flechner SM; Kolbeinsson MC; Lum B; Tam J; Moran T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1446-8. PubMed ID: 2652464
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with cyclosporine of adult idiopathic nephrotic syndrome resistant to corticosteroids and other immunosuppressants.
    Meyrier A; Condamin MC; Simon P
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):259-61. PubMed ID: 3381278
    [No Abstract]   [Full Text] [Related]  

  • 18. Disappearance of pulmonary capillary leak syndrome when intravenous cyclosporine is replaced by oral cyclosporine.
    Blaauw AA; Leunissen KM; Cheriex EC; Wolters J; Kootstra G; Van Hooff JP
    Transplantation; 1987 May; 43(5):758-9. PubMed ID: 3554668
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylactic reaction to intravenous cyclosporine.
    Chapuis B; Helg C; Jeannet M; Zulian G; Huber P; Gumovski P
    N Engl J Med; 1985 May; 312(19):1259. PubMed ID: 3990720
    [No Abstract]   [Full Text] [Related]  

  • 20. Fractional excretion of protein: a marker of the efficacy of cyclosporine A treatment in nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):280-4. PubMed ID: 3381284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.